2 Dec 2020 09:31
Medica Group PLC
Director / PDMR Transaction and Shareholding
Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Dr Stephen Davies, Medical Director and Responsible Officer of Medica, that on 30 November 2020 he transferred a total of 521,032 ordinary shares of 0.2p in the Company ("Shares") to his wife, Mary Davies, for nil consideration. In addition, Stephen Davies and his wife have sold a total of 1,079,292 ordinary shares at a price of 120.00p per share.
Following these transactions, Stephen Davies has an interest in 576,634 shares, representing 0.5% of the issued share capital of the Company.
Furthermore, the Company also received a notification from Dr Stuart Quin, Chief Executive Officer of Medica Group PLC, that on 1 December 2020 he transferred a total of 60,000 ordinary shares of 0.2p in the Company ("Shares") to his wife Mallika Quin, for nil consideration. Following this transaction, there has been no change in the number of shares in which Stuart Quin has an interest.
The Notification of Dealing Forms for Dr Stephen Davies and Dr Stuart Quin can be found below.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name | Dr Stephen Davies | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Medical Director and Responsible Officer/PDMR
| ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Medica Group PLC | ||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | ||||
|
| |||||
b)
| Nature of the transaction
| Transfer of Ordinary Shares to Mary Davies | ||||
c) | Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggrated volume - Price
|
521,032 N/A
| ||||
e)
| Date of the transaction
| 30 November 2020 | ||||
f)
| Place of the transaction
| Outside a trading venue | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name | Dr Stephen Davies | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Medical Director and Responsible Officer/PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Medica Group PLC | ||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | ||||
|
| |||||
b)
| Nature of the transaction
| Market sale | ||||
c)
| Price(s) and volume(s) |
| ||||
d)
| Aggregated information - Aggrated volume - Price
|
1,031,924 GBP 120.00 | ||||
e)
| Date of the transaction
| 30 November 2020 | ||||
f)
| Place of the transaction
| XLON | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||
a)
| Name | Mary Davies | |||||
2
| Reason for the notification
| ||||||
a)
| Position/status
| PCA/ Dr Stephen Davies (Medical Director and Responsible Officer) | |||||
b)
| Initial notification /Amendment
| Initial notification | |||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||
a)
| Name
| Medica Group PLC | |||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | |||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | |||||
|
| ||||||
b)
| Nature of the transaction
| Market sale | |||||
c)
| Price(s) and volume(s) |
|
| ||||
d)
| Aggregated information - Aggrated volume - Price
|
47,368 GBP 120.00 | |||||
e)
| Date of the transaction
| 30 November 2020 | |||||
f)
| Place of the transaction
| XLON | |||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name | Dr Stuart Quin | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Executive Officer/PDMR
| ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Medica Group PLC | ||||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p
GB00BYV24996 | ||||
|
| |||||
b)
| Nature of the transaction
| Transfer of Ordinary Shares to Mallika Quin | ||||
c) | Price(s) and volume(s) |
| ||||
d)
| Aggregated information - Aggrated volume - Price
|
60,000 GBP 0
| ||||
e)
| Date of the transaction
| 1 December 2020 | ||||
f)
| Place of the transaction
| Outside a trading venue | ||||